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ABSTRACT
Bacground and aim: There are few reports from Iran about the epidemiology and clinical
features of inflammatory bowel disease (IBD). In this study, we aimed to determine the
epidemiologic profile and clinical features of ulcerative colitis (UC) in Northwest of Iran.
Methods: This retrospective study covered the time period from 1998 to 2008 and included all
patients of a private gasteroenterology clinic in the northwest of Iran, who had diagnosis of
UC at the time of presentation or those whose diagnosis had been made later. In addition to
description of epidemiology and clinical feature of disease, an attempt was made to identify
factors associated with severity of disease.
Results: A total of 105 patients including 61 females (58.1%) were evaluated. Mean age of the
patients was 33.5 ± 13.1 years. The median time interval from initiation of symptoms to diagnosis
was 9 months. The commonest presentation was proctosigmoiditis. (48.6%). Among extra-
intestinal manifestations, sclerosing cholangitis had the highest frequency and was found in
2 (1.9%) patients. Among all evaluated variables, only family income (the higher the income
the more severe the disease) and cigarette smoking (inverse association) were find to have
significant association with severity of disease.
Conclusion: A case profile of patients with ulcerative colitis from Northwest Iran suggests
that the disease is seen most commonly in the third decade of life with a female preponderance.
Family income and smoking  influenced the course of ulcerative colitis in Iranian patients.
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Introduction
Inflammatory bowel disease (IBD) consists of Crohn’s disease
(CD), ulcerative colitis (UC), and indeterminate colitis.1
Although the etiology of IBD has not been well defined, it has
been suggested that it can be triggered by environmental,
genetic, and immunologic factors.2 The highest incidence of
both CD and UC has been reported from the Northern Europe,
United Kingdom, and North America.3,4 However, recent studies
demonstrated that the incidence of IBD is increasing in other
parts of the world as well.5-7 In spite of the increasing trend in
other parts of the globe, there are limited data regarding
epidemiology and clinical feature of IBD from underdeveloped
countries4and the pattern of IBD has not been well illustrated
in these countries. Studying the epidemiologic profile of IBD
including UC in different areas may help researchers to identify
etiologic factors of these diseases.6
Although the reason for this increasing trend is not clear,
some theories suggested that improvements in general health
and hygiene are contributing factors for increasing incidence
of IBD. Urbanization, exposure to certain infections such as
measles, industrialization, and adaptation of western lifestyle
have all been incriminated as probable factors that influence
incidence of IBD.2,8
Similar to other parts of the globe, previous reports from
Iran demonstrated increasing incidence of UC in Iran.2,9,10 Since
these studies were performed in referral centers in Tehran,
capital of Iran, the studied samples may not have been fully
representative of Iranian society, as Iran is a wide geographic
country of different ethnicities. Thus, it seems that further
studies with a focus on clinical features of IBD are needed to
elucidate the pattern of IBD including UC in Iran. In the present
study, therefore, we aimed to determine the epidemiologic profile
and clinical features of UC in patients who presented to a
medical office in Northwest of Iran.
Methods
This retrospective study covered the time period from 1998 to
2008 and included all patients of UC who presented to a private
gastroenterology referral clinic in northwest Iran, and were
diagnosed with UC either at presentation or later. Patients with
the diagnosis of CD were not included due to their low numbers.
Patients with incomplete records were also excluded.
Demographics, habits and past medical history,
colonoscopic findings, major extra-intestinal manifestations
(musculoskeletal, mucocutaneous, hepatic, ophthalmic, and
urinary tract involvement), severity of disease, treatment
details, and duration of follow up were obtained by reviewing
the patients records.
The diagnosis of UC was made if patients had history of
diarrhea or presence of blood and pus, or both, in the stool for
more than 4 weeks; presence of characteristic colonoscopic
features with diffusely granular, friable, or ulcerated mucosa
with rectal involvement and absence of skip lesions; and
histopathologic findings compatible with diagnosis of UC on
biopsy.6 Severity of UC was determined as previously
described by Edwards and Truelove.11
All statistical analyses were performed using SPSS (SPSS
Inc., Chicago IL.) version 15. Numerical data has been
expressed as mean ± standard deviation. Spearman correlation
and Lamda statistic were used to analyze data. A p value <
0.05 was considered to be statistically significant.
Results
A total of 105 patients including 61 females (58.1%) were
evaluated. Mean age of the patients was 33.5 ± 13.1 years
(range 12 to 80 years). Table 1 demonstrates the characteristics
of our study subjects.  No patient had history of either
tonsillectomy or appendectomy. The median time interval from
initiation of symptoms to diagnosis was 9 months (range 1 to
120 months). Mean duration of follow up ranged from 3 to 108
months with a mean of 41.8±24.0 months.
Table 2 demonstrates the frequency of involvement of
various segments of colon in the patients. As the table shows,
the rectosigmoid was the most frequent segment. Among extra-
intestinal manifestations of ulcerative colitis, sclerosing
cholangitis had the highest frequency and was found in 2
(1.9%) patients (Table 3).
Regarding the type of treatment, all cases had received
either Sulfasalazine or Mesalamine while only 24 cases (22.9%)
had been treated with corticosteroids. Surgery  was performed
Table 1: Characteristics of the studied patients
Frequency Percent
Married 85 81
Living in urban 88 83.8
High education 13 12.4
Family income
•  Low 36 34.3
• Middle 62 59
•  High 7 6.7
Smoking history 11 10.4
Oral contraceptive pill consumptions 4 3.9
Alcohol drinking 3 2.9
Opium addiction 1 1
Table 2: Frequency of involved segments of colon
Frequency Percent
Rectum 33 31.4
Rectosigmoid 51 48.6
Left colon 17 16.2
Pancolitis 4 3.8
in 2 (1.9%) subjects. Good and moderate responses to treatment
were seen in 94 (89.5%) and 9 (8.5%) patients respectively,
while 2 patients (1.9%) had refractory disease. Figure 1 depicts
the frequency of patients according to the severity of disease.
As the figure demonstrates, most of the patients had mild UC.
We assessed the association between severity of disease
and other study variables. Among all evaluated variables, only
family income (the higher the income the more severe the
disease) and cigarette smoking (inverse association) were find
to have significant association with severity of disease (Table
4). There was no significant association between the prescribed
drugs and response to treatment (p=0.06).
Discussion
The present study aimed to describe the epidemiologic profile
and clinical presentations of UC in northwest of Iran. In the
present study, we found that UC is more frequent in females,
which is in agreement with previous reports from Iran.2,9,12 It is
relatively similar to a report from South Korea which showed
slight higher incidence of UC in females.6 However, some
studies have failed to note a greater incidence of UC in
females.13,14 Indeed, female predominance has been shown in
Crohn’s disease and a role for estrogens and progesterones
has been postulated, though it is not the same with UC.3  In our
study, the mean age of patients was 33.5 ± 13.1 years, which is
a younger than the mean age of UC patients in another report
from Iran.12
In our study, 8 patients (7.6%) had extra-intestinal
manifestations which is lower than other reports from Iran.2,9
In the studies conducted by Aghazadeh et al9and Vahedi et al2,
31.4% and 62.4% of the studied UC patients had extra-intestinal
manifestations, respectively. The difference between our results
and these reports may be explained by our relatively small
sample size, the accuracy of diagnostic evaluations, and
difference in definitions. However, our results are relatively
close to the incidence reported by Jiang et al. who reviewed
10,218 UC patients.13 They reported extra-intestinal features in
6.1% of their patients. In the study conducted by Aghzadeh
and associates9, mucocutaneous lesions were the most
frequent extra-intestinal feature while Vahedi et al2reported the
musculoskeletal features as most frequent manifestations. In
our study, primary sclerosing cholangitis was the most common
extra-intestinal manifestation.
Rectosigmoid segment of the colon was the most frequently
involved part of the colon in our study, and was found involved
in 48.6% of the studied patients. Rectum (alone), left colon,
and pancolitis were next most frequent sites, similar to previous
reports from Iran2,9 Vahedi and colleagues by evaluating 293
cases of UC reported proctitis in 149, left colitis in 94, and
pancolitis in 50 cases.2  In another report from Iran, Aghazadeh
et al. evaluated 283 cases of UC and reported proctitis in 147,
involvement of left colon in 85, and pancolitis in 51 cases.9
In the present study, we found that cigarette smokers have
milder disease compared to non-smokers. An inverse
association has been reported between cigarette smoking and
UC.3,15-17 Although the exact reason for this phenomenon is
Figure 1: Frequency of patients according to the severity of disease
Table 3: Extra-intestinal manifestations of ulcerative colitis
in studied patients.
n (%)
Autoimmune hepatitis/Cirrhosis  1 (0.9%)
Arthritis 1 (0.9%)
Erythema nodosum 1 (0.9%)
Primary sclerosing cholangitis 2 (1.9%)
Hyperthyroidism 1 (0.9%)
Hypothyroidism 1 (0.9%)
Aphthous ulcers (oral) 1 (0.9%)
Table 4: Factors demonstrating a significant association with
severity of ulcerative colitis
Severity of Disease P-value
Mild Moderate Severe
N (%) N (%) N (%)
Family income
•  Low 19 (52.8) 14 (38.9) 3 (8.3) 0.04†
•  Middle 30 (48.4) 17 (27.4) 15 (24.2)
•  High 1 (14.3) 1 (14.3) 5 (71.4)
Cigarette smoking
•  Positive 10 (83.3) 1 (8.3) 1 (8.3) 0.04‡
•  Negative 42 (45.2) 30 (32.3) 21 (22.6)
† Spearman correlation. ‡ Lamda statistic.
unclear, some hypotheses such as the effects of  nicotine on
colonic mucus,  rectal blood flow, cytokines, and eicosanoids
have been postulated.3,18 Moreover, other studies have showed
that cigarette smoking can influence the course of UC and
decreases hospitalization rates and improve UC symptoms.19,20
Therefore, our results confirm the previous studies in this
regard. However, some authors did not find a significant relation
between UC and cigarette smoking.13 In this study, we also
showed an association between family income and severity of
UC, with a higher family income bearing relationship with more
severe disease. This finding is relatively in agreement with a
study by Green et al. that showed an association between high
socioeconomic level and risk of UC.21 In the aforementioned
study, socioeconomic status was generated from three
components of average family income, unemployment rate, and
educational level.21
This study attempted to determine the epidemiologic profile
and clinical manifestations of UC in northwest of Iran. Our
study also showed that family income and smoking can
influence the course of UC.
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